![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
Advertisement
All
>
Persons > Northern Europe
Please find below persons from Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden and the UK as well as related to organisations from these countries.Total search results: 4175 | Ordered by Person (ascending)
1 2 3 ... 40 41 42 
  Person |
 Position |
Organisation (Group) |
Country |
|---|---|---|---|
| Aabo, Gitte (Leo Pharma 201511 CEO) | Chief Executive Officer (CEO) | Leo Pharma (Group) | Denmark |
| Aamund, Asger (Bavarian Nordic 200804 Chairman) | n. a. | Bavarian Nordic (Group) | Denmark |
| Aasen, Ove T. (DiaMan AS 201804 CEO) | Chief Executive Officer (CEO) | DiaMan AS | Norway |
| Aastrup, Teodor (Attana 200502) | n. a. | Attana (Group) | Sweden |
| Aastveit, Are (Norwegian University for Biosciences and the Environment 200601) | n. a. | Norwegian University of Life Sciences (UMB) | Norway |
| Abate, Emmanuel (Danaher 202210 President Genomic Medicine at Cytiva) | President/Director/Head Business Group/Unit/Division | Danaher (Group) | United Kingdom (GB) |
| Abbott, Mark (Peak Proteins 202204 CEO) | Chief Executive Officer (CEO) | Sygnature Discovery (Group) | United Kingdom (GB) |
| Abbott, Rachel (Pan Cancer T 202305– CEO joined as CSO 1/23 before Enara Bio + Adaptimmune) | Chief Executive Officer (CEO) | Pan Cancer T B.V. | Netherlands |
| Abbott, Raymond (Albany Ventures) | n. a. | Albany Ventures (Group) | United Kingdom (GB) |
| Abdullah, Hesham (GSK 202310 SVP Global Head Oncology RnD) | Research & Development Manager | GSK (Group) | United Kingdom (GB) |
| Abery, Julian (BioCity (GB) 201909– Director Business Development North America at BioAscent Discovery) | Business Development Manager / Strategy Manager | Pioneer Group, The (WAPG) (Group) | United Kingdom (GB) |
| Absalonsen, Karin (Hannibal Innovation 202310) | n. a. | Hannibal Innovation ApS | Denmark |
| Abu-Rabie, Paul (GSK 201010 Principal Scientist Bioanalytical Science & Development GSK R&D UK) | Researcher (industry) | GSK (Group) | United Kingdom (GB) |
| Acosta, Colleen (Freya Biosciences 20231212 CEO + Co-Founder) | Chief Executive Officer (CEO) | Freya Biosciences ApS | Denmark |
| Acton, Gary (Antisoma 200604– CMO) | n. a. | Sarossa Capital (Group) | United Kingdom (GB) |
| Adair, Fiona (Haptogen 200507– before Biovation + CXR Biosciences) | n. a. | Pfizer (Group) | United Kingdom (GB) |
| Adam, Maxine (United Kingdom (govt) 202310 Head of Business Growth at Innovate UK) | Business Development Manager / Strategy Manager | United Kingdom (GB) (govt) | United Kingdom (GB) |
| Adams, Nicholas (Clavis Pharma 201107– CBO before Antisoma since 1999 BusDev Director + Manager + Ciba-Geiga + Eisai) | Chief Business Officer (CBO) | Aqualis ASA | Norway |
| Adkins, John (Sterilin 200806 CEO) | Chief Executive Officer (CEO) | Thermo Fisher (Group) | United Kingdom (GB) |
| Adlam, Leila (Inizio 202401 at Medistrava Consulting) | Public Relations Manager / Investor Relations Manager | Inizio (Group) | United Kingdom (GB) |
| Adlersson, Lars (Medivir 200609 CEO + President) | Chief Executive Officer (CEO) | Medivir (Group) | Sweden |
| af Winklerfelt, Michael (Oasmia 202008 CFO) | Chief Financial Officer (CFO) | Oasmia Pharmaceutical AB | Sweden |
| Affara, Nabeel (Cambridge Univ Molecular Genetics Group 200211) | n. a. | University of Cambridge | United Kingdom (GB) |
| Afshar, Ali (Cytera Cellworks 202011 CEO + Co-Founder) | Chief Executive Officer (CEO) | Cytera CellWorks Ltd. | United Kingdom (GB) |
| Aggarwal, Vijay (Aureon Laboratories 200410– before SKB + Quest Diagnostics) | n. a. | Aureon Laboratories Inc. | United States (USA) |
| Agger, Mette Kirstine (Lundbeck 201411 Managing Partner at Lundbeckfonden Ventures before 7TM Pharma CEO) | Managing Partner (investment firm) | Lundbeck (Group) | Denmark |
| Aguiar-Lucander, Renée (Pharmalink AB 201708 CEO) | Chief Executive Officer (CEO) | Calliditas Therapeutics (Group) | Sweden |
| Ahanola, Jani (Noona Healthcare 201611 CEO) | Chief Executive Officer (CEO) | Noona Healthcare (FI) | Finland |
| Ahlberg, Christer (Cinclus Pharma 202106– CEO before Sedana Medical Group) | Chief Executive Officer (CEO) | Cinclus Pharma (Group) | Sweden |
| Ahmed, J. Omee (Alto Marketing 201512) | Public Relations Manager / Investor Relations Manager | Alto Marketing Ltd. | United Kingdom (GB) |
| Ahomäki, Satu (Orion Corp 202001 SVP Commercial Operations) | Chief Commercial Officer (CCO) | Orion Corporation (Group) | Finland |
| Ahrens, Nikolai (Turos Capital 2018– Founder + CEO + LifeScience Connect 2020 Founder) | n. a. | Turos Capital AG | Switzerland |
| Aithani, Lakshyaditya Singh (Laksh) (Charm Therapeutics 202206 CEO + Co-Founder before Braavos + Exscientia + genei) | Chief Executive Officer (CEO) | Charm Therapeutics Ltd. | United Kingdom (GB) |
| Aitman, Tim (CSC/Imperial College London 200503) | Professor | United Kingdom (GB) (govt) | United Kingdom (GB) |
| Akay, Ingrid Teigland (Hadean Ventures 201604 Managing Director) | Managing Director | Hadean Ventures AS | Norway |
| Alajmovic, Sana (Sigrid Therapeutics 201909 CEO + Co-Founder) | Chief Executive Officer (CEO) | Sigrid Therapeutics AB | Sweden |
| Alamaa, Marie-Louise (PledPharma 202011 CFO) | Chief Financial Officer (CFO) | Egetis Therapeutics (Group) | Sweden |
| Alanine, Alexander (Bactevo 201704– COO before Roche) | Chief Operating Officer (COO) | Astellas (Group) | United Kingdom (GB) |
| Alavijeh, Mohammad (Pharmidex 200602 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Pharmidex Pharmaceutical Services Ltd. | United Kingdom (GB) |
| Albertella, Mark (Storm Therapeutics 201905– VP Translational Oncology before Medivir + Argenta + OSI Pharmaceuticals) | Research & Development Manager | Storm Therapeutics Ltd. | United Kingdom (GB) |
| Albinus, Bjørn (Cheminova 200504 Managing Director) | Managing Director | Auriga Industries (Group) | Denmark |
| Albisser, Zeno (Hemispherian 202105 CEO) | Chief Executive Officer (CEO) | Hemispherian AS | Norway |
| Albrecht, Claudio (Actavis 201201 CEO) | Chief Executive Officer (CEO) | Teva (Group) | Iceland |
| Albrechtsen, Morten (Nanovi ApS 201311 CEO + Co-founder) | Chief Executive Officer (CEO) | Nanovi A/S | Denmark |
| Albright, Kristen (Prokarium 202010– promoted to COO) | Chief Operating Officer (COO) | Prokarium Ltd. | United Kingdom (GB) |
| Alder, Matthias (Autolus 201707– CBO + General Counserl before Sucampp + Cytos Biotechnology + Micromet + Cooley LLP) | Chief Business Officer (CBO) | Autolus Therapeutics plc (Nasdaq: AUTL) | United Kingdom (GB) |
| Aleksik, Jelena (PharmEnable 202012 CBO before GeneAdviser) | Chief Business Officer (CBO) | PharmEnable Ltd. | United Kingdom (GB) |
| Alenfall, Jan (Follicum 201902 CEO) | Chief Executive Officer (CEO) | Follicum AB | Sweden |
| Alevizopoulos, Konstantinos (APIM Therapeutics 201210 CEO) | Chief Executive Officer (CEO) | APIM Therapeutics AS | Norway |
| Alfaiate, Maria (Lundbeck 202408– EVP Commercial + Corporate Strategy before Bayer + AstraZeneca + MSD/Merck) | Business Development Manager / Strategy Manager | Lundbeck (Group) | Denmark |
| Alfheim, Jan A. (Oncoinvent 202006 CEO) | Chief Executive Officer (CEO) | Oncoinvent AS | Norway |
| Ali, Batoul (Instinctif Partners 202305) | Public Relations Manager / Investor Relations Manager | Instinctif Partners (Group) | United Kingdom (GB) |
| Ali, Iraj (Achilles Therapeutics 201812– CEO before Interim CEO + Syncona + McKinsey) | Chief Executive Officer (CEO) | Achilles Therapeutics (Group) | United Kingdom (GB) |
| Allan, Eva-Lotta (Immunocore 201305– CBO before Ablynx 200606– CBO before Vertex Pharmaceuticals) | Chief Business Officer (CBO) | Immunocore (Group) | United Kingdom (GB) |
| Allcroft, Louise (Complement Genomics 200902 CEO) | Chief Executive Officer (CEO) | Complement Genomics Ltd. | United Kingdom (GB) |
| Allen, Allison (Biovian 202209– Business Development Manager based in US before Cellectis + Alcami + Thermo Fisher) | Business Development Manager / Strategy Manager | Biovian Oy | Finland |
| Allen, Chris (Broughton Laboratories 2011– Managing Director joind as Co-Founder 2006 before Sciantec Analytical) | Managing Director | Broughton Laboratories (GB) | United Kingdom (GB) |
| Allen, Dave (GSK 201609 SVP KSG Pharma RnD) | n. a. | GSK (Group) | United Kingdom (GB) |
| Allen, Mark (Tripos 200508) | n. a. | Provid Pharmaceuticals (Group) | United Kingdom (GB) |
| Allen, Peter (Celltech 1992–2004 CFO) | Board member, non-executive | UCB (Group) | United Kingdom (GB) |
| Allenby, Gary (Aurelia Bioscience 202106 Co-Founder) | Company Founder | Charnwood Molecular (Group) | United Kingdom (GB) |
| Allin, Steve (Charnwood Molecular 202207– Board Advisor + Investor before 1998–202207 CEO + Co-Founder) | Board member (all kinds of boards: supervisory, advisory, management etc.) | Charnwood Molecular (Group) | United Kingdom (GB) |
| Allinson, John (Icon plc 201011 VP Biomarker Lab Services) | n. a. | Icon plc (Group) | Ireland, Republic of |
| Allmond, David (Novacyt 202110 CEO before Amryt Pharma + Amgen + Celgene + Aegerion Pharmaceuticals) | Chief Executive Officer (CEO) | Novacyt (Group) | France |
| Allott, Stephen (Trinamo Ltd. 200708 Executive Chairman) | Board member, executive | Danaher (Group) | United Kingdom (GB) |
| Almeida, José E. (Covidien 201112 CEO) | Chief Executive Officer (CEO) | Covidien (Group) | Ireland, Republic of |
| Almond, Andrew (Imperagen 202208 CEO + Founder formerly Co-Founder of Conformetrix/C4X Discovery) | Chief Executive Officer (CEO) | Imperagen Ltd. | United Kingdom (GB) |
| Almond-Thynne, Joshua (Sablebio 202308– Director + Co-Founder before BenevolentAI) | Managing Director | Sablebio Ltd. (Sable Bio) | United Kingdom (GB) |
| Alriksson, Maria (Abera Bioscience 202203 CEO) | Chief Executive Officer (CEO) | Abera Bioscience AB | Sweden |
| Alsbo, Carsten (Exiqon 200904 Product Manager) | Product Manager (personnel) | Qiagen (Group) | Denmark |
| Altieri, Richard M. (Rick) (Oxford Immunotec 201311 CFO) | Chief Financial Officer (CFO) | Oxford Immunotec (Group) | United Kingdom (GB) |
| Álvarez-Martos, Isabel (Cellugy 202012 CEO + Co-Founder) | Chief Executive Officer (CEO) | Cellugy (DK) | Denmark |
| Amado, Rafael G. (Allogene 201909– EVP RnD + CMO before Adaptimmune + GSK + Amgen + UCLA) | Chief Medical Officer (CMO) | Allogene Therapeutics Inc. (Nasdaq: ALLO) | United States (USA) |
| Ameri, Jacqueline (Pancryos 202205 CEO + Co-Founder) | Chief Executive Officer (CEO) | Pancryos ApS | Denmark |
| Ameye, Veronique (LumiraDx 202312 CEO) | Chief Executive Officer (CEO) | LumiraDx (Group) | United Kingdom (GB) |
| Amiel, Laurent (General Electric 201005 General Manager EMEA GE Healthcare Performance Solutions) | General Manager (management) | General Electric (Group) | United Kingdom (GB) |
| Amijee, Hozefa (Ubiquigent 202211– Head of Business Development before Cellesce + RxCelerate + Total Scientific) | Business Development Manager / Strategy Manager | Ubiquigent Ltd. | United Kingdom (GB) |
| Amin, Naseem (Arix Bioscience 202011 Executive Chairman) | Board member, executive | Arix Bioscience (Group) | United Kingdom (GB) |
| Andersén, Hedvig (Sweden (govt) 201201 Life Science Investment Manager at Industrifonden) | Investment Manager | Sweden (govt) | Sweden |
| Andersen, Peder M. (Biosergen 202104 CEO) | Chief Executive Officer (CEO) | Biosergen AB | Sweden |
| Andersen, Thomas (Nextera AS 201510 CEO) | Chief Executive Officer (CEO) | Nextera AS | Norway |
| Andersin, Kati (Biohit 200905 Product Group Manager) | Product Manager (personnel) | Biohit (Group) | Finland |
| Anderson (formerly Broder), Elizabeth (LianBio 202103 VP Communications + IR before MeiraGTx) | Public Relations Manager / Investor Relations Manager | LianBio | |
| Anderson, Diana (Univ Bradford 201408 Professor at Faculty of Life Sciences) | Professor | University of Bradford | United Kingdom (GB) |
| Anderson, Joe (Perceptive Bioscience 201603 CEO) | Chief Executive Officer (CEO) | Perceptive Bioscience Investments Ltd. | United Kingdom (GB) |
| Anderson, Joe (Sofinnova Partners 2022 Partner before Arix Bioscience + Abingworth) | Investment Manager | Sofinnova (Group) | France |
| Anderson, Richard (Sciad Communications Co-founder before Bell-Pottinger + Founder of De Facto ) | Managing Partner | Sciad Communications Ltd. | United Kingdom (GB) |
| Andersson, Ann-Sofie (Copenhagen (govt) 201701 Business Development Manager Life Sciences at Copenhagen Capacity) | Business Development Manager / Strategy Manager | Copenhagen (govt region) | Denmark |
| Andersson, Claus A. (Sunstone Capital 201511 Partner Life Sciences) | Partner (venture partner) | Sunstone Life Science (Group) | Denmark |
| Andersson, Poul (DTU 201404 CEO of Bioneer A/S) | Chief Executive Officer (CEO) | Technical University of Denmark (DTU) | Denmark |
| Andersson, Thomas (Lund Univ 201202 CEO of LU Bio) | Chief Executive Officer (CEO) | University of Lund (Lund University) | Sweden |
| Andréasson, Sven (Active Biotech 199901–200808 President + CEO) | Chief Executive Officer (CEO) | Active Biotech (Group) | Sweden |
| Andrejauskas, Tomas (Lithuanian Biotechnology Association) | Cluster Manager | Lithuanian Biotechnology Association (LBTA, Lietuvos Biotechnologu Asociacija) | Lithuania |
| Andresen, Thomas Lars (T-Cypher Bio 202108– CEO before Torque Therapeutics + Monta Biosciences + Nanovi) | Chief Executive Officer (CEO) | T-Cypher Bio Ltd. | United Kingdom (GB) |
| Andreu, Fernando (2curex 202101– before Indivumed + Sysmex Inostics) | Chief Executive Officer (CEO) | 2cureX (Group) | Denmark |
| Angelici, Bruno (AstraZeneca 200812 Executive VP Intern Sales + Marketing) | Sales Manager / Marketing Manager | AstraZeneca (Group) | United Kingdom (GB) |
| Angelin, Bo (Karolinksa Univ Hospital –200707–) | n. a. | Karolinska Institutet | Sweden |
| Angell, Richard M. (Draig Therapeutics 202401 CEO + Commercialisation Lead) | Chief Executive Officer (CEO) | Draig Therapeutics Ltd. | United Kingdom (GB) |
| Ankarberg, Mattias (Sigrid Therapeutics 202301 Board Chair formerly at H&M) | Board member, non-executive | Sigrid Therapeutics AB | Sweden |
| Annable, Mike (Lab21 201202 Director Clinical Lab division) | Laboratory Manager (industry) | Novacyt (Group) | United Kingdom (GB) |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
